World's Best Scientists 2026 revealed!
Award Badge
Immunology
Sweden
2026
Award Badge
Immunology
Belgium
2025

D-Index & Metrics

Immunology

D-Index
145
Citations
105931
World Ranking
137
National Ranking
2

Medicine

D-Index
145
Citations
106162
World Ranking
1361
National Ranking
28

Research.com Recognitions

  • 2026 - Research.com Immunology in Sweden Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award
  • 2023 - Research.com Immunology in Belgium Leader Award
  • 2022 - Research.com Immunology in Belgium Leader Award
  • 2014 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Ophthalmology, Oto-Rhino-Laryngology and Stomatology

Overview

Claus Bachert is affiliated with Ghent University in Belgium. Their research primarily focuses on the fields of medicine, notably within immunology and allergy, otorhinolaryngology, physiology, surgery, and pulmonary and respiratory medicine.

The scientist has contributed extensively to several primary research topics, including:

  • Allergic Rhinitis and Sensitization
  • Sinusitis and nasal conditions
  • Asthma and respiratory diseases
  • Nasal Surgery and Airway Studies
  • Respiratory and Cough-Related Research
  • Dermatology and Skin Diseases
  • Olfactory and Sensory Function Studies

Claus Bachert's research has been published in several key scientific journals, with notable frequency in:

  • Journal of Allergy and Clinical Immunology
  • Allergy
  • The Journal of Allergy and Clinical Immunology In Practice
  • Laryngo-Rhino-Otologie
  • Annals of Allergy Asthma & Immunology

Among their recent publications are:

  • European Position Paper on Rhinosinusitis and Nasal Polyps 2020, published in 2020 in Rhinology Journal
  • International consensus statement on allergy and rhinology: rhinosinusitis 2021, published in 2020 in International Forum of Allergy & Rhinology
  • Allergic rhinitis, published in 2020 in Nature Reviews Disease Primers
  • Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials, published in 2020 in Journal of Allergy and Clinical Immunology
  • Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial, published in 2021 in The Lancet Respiratory Medicine

They have collaborated frequently with several co-authors, including:

  • Joaquim Mullol
  • Ludger Klimek
  • Wytske J. Fokkens
  • Peter W. Hellings
  • Philippe Gevaert

Claus Bachert has been recognized with the German National Academy of Sciences Leopoldina award in 2014 for contributions in ophthalmology, oto-rhino-laryngology, and stomatology.

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

    Wytske J. Fokkens;Valerie J. Lund;Joachim Mullol;Claus Bachert

  • European Position Paper on Rhinosinusitis and Nasal Polyps 2020

    Wytske J. Fokkens;Valerie J. Lund;Joachim Mullol;Claus Bachert

  • Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

    Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal

  • Rhinosinusitis: Establishing definitions for clinical research and patient care

    Eli O. Meltzer;Daniel L. Hamilos;James A. Hadley;Donald C. Lanza

  • Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

    Claus Bachert;Claus Bachert;Joseph K Han;Martin Desrosiers;Peter W Hellings

  • Chronic rhinosinusitis in Europe : an underestimated disease. A GA²LEN study

    D Hastan;WJ Fokkens;Claus Bachert;RB Newson

  • Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.

    Peter Tomassen;Griet Vandeplas;Thibaut Van Zele;Lars-Olaf Cardell

  • Consensus statement * on the treatment of allergic rhinitis

    P van Cauwenberge;C Bachert;G Passalacqua;J Bousquet

  • Differentiation of chronic sinus diseases by measurement of inflammatory mediators.

    T. Van Zele;S. Claeys;P. Gevaert;G. Van Maele

  • Rhinosinusitis: developing guidance for clinical trials.

    Eli O. Meltzer;Daniel L. Hamilos;James A. Hadley;Donald C. Lanza

  • Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.

    Claus Bachert;Philippe Gevaert;Gabriele Holtappels;S.G.O. Johansson

  • Practical guide to skin prick tests in allergy to aeroallergens

    J. Bousquet;J. Bousquet;L. Heinzerling;C. Bachert;N. G. Papadopoulos

  • Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial

    Claus Bachert;Claus Bachert;Leda Mannent;Robert M Naclerio;Joaquim Mullol

  • International consensus statement on allergy and rhinology: rhinosinusitis 2021

    Richard R. Orlandi;Todd T. Kingdom;Timothy L. Smith;Benjamin Bleier

  • Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

  • Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation.

    Dmitri V. Krysko;Patrizia Agostinis;Olga Krysko;Abhishek D. Garg

  • Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.

    Philippe Gevaert;Nicholas Van Bruaene;Tom Cattaert;Kristel Van Steen

  • Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease.

    Nan Zhang;Thibaut Van Zele;Claudina Perez-Novo;Nicholas Van Bruaene

  • Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

    Cezmi A. Akdis;Claus Bachert;Cemal Cingi;Mark S. Dykewicz

Frequent Co-Authors

Jean Bousquet
Jean Bousquet University of Montpellier
Philippe Gevaert
Philippe Gevaert Ghent University
Gabriele Holtappels
Gabriele Holtappels Ghent University
Ludger Klimek
Ludger Klimek Ghent University
Joaquim Mullol
Joaquim Mullol University of Barcelona
Torsten Zuberbier
Torsten Zuberbier Charité - University Medicine Berlin
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Pascal Demoly
Pascal Demoly University of Montpellier
David Price
David Price University of Aberdeen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees can open diverse career pathways. Many students begin with foundational nursing programs before specializing further. Online ADN programs for non nurses offer a flexible entry point for individuals transitioning into nursing without prior experience.

Accelerated options like the easiest ABSN program to get into provide a fast track for students who already hold a bachelor’s degree in another field. These programs allow learners to earn a Bachelor of Science in Nursing efficiently while gaining critical clinical skills.

Entry-level programs such as LPN programs with easiest admission requirements are ideal for those seeking quicker certification and practical nursing roles. These programs emphasize bedside care and can be a stepping stone toward advanced practice degrees.

For advanced clinical roles, the easiest NP program can guide students toward becoming Nurse Practitioners, blending specialized patient care with opportunities in research and immunology-focused healthcare settings.

Best Scientists Citing Claus Bachert

Trending Scientists